Aspen Aerogels Q3 EPS Estimate Boosted by Seaport Res Ptn

Aspen Aerogels, Inc. (NYSE:ASPN) – Investment analysts at Seaport Res Ptn lifted their Q3 2025 earnings per share estimates for shares of Aspen Aerogels in a research note issued to investors on Wednesday, August 13th. Seaport Res Ptn analyst T. Curran now expects that the construction company will earn $0.02 per share for the quarter, up from their prior estimate of ($0.05). The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.17 per share. Seaport Res Ptn also issued estimates for Aspen Aerogels’ Q4 2025 earnings at $0.02 EPS, FY2025 earnings at ($0.06) EPS, Q1 2026 earnings at ($0.04) EPS, Q2 2026 earnings at ($0.03) EPS, Q3 2026 earnings at $0.03 EPS, Q4 2026 earnings at $0.06 EPS, FY2026 earnings at $0.02 EPS and FY2027 earnings at $0.44 EPS.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings results on Thursday, August 7th. The construction company reported ($0.04) EPS for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.08. Aspen Aerogels had a positive return on equity of 2.92% and a negative net margin of 78.53%. The company had revenue of $78.02 million during the quarter, compared to analysts’ expectations of $72.53 million. During the same period in the prior year, the company earned $0.21 EPS. Aspen Aerogels’s revenue was down 33.8% compared to the same quarter last year.

A number of other analysts also recently weighed in on ASPN. Canaccord Genuity Group decreased their price objective on Aspen Aerogels from $11.00 to $10.00 and set a “buy” rating for the company in a report on Friday, August 8th. Barclays downgraded Aspen Aerogels from an “equal weight” rating to an “underweight” rating and increased their price objective for the company from $7.00 to $16.00 in a report on Monday, August 11th. Finally, Oppenheimer downgraded Aspen Aerogels from an “outperform” rating to a “market perform” rating in a report on Thursday, May 8th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $19.50.

Aspen Aerogels Stock Performance

NYSE ASPN opened at $7.25 on Monday. The company has a market capitalization of $597.11 million, a price-to-earnings ratio of -1.90 and a beta of 2.73. Aspen Aerogels has a twelve month low of $4.16 and a twelve month high of $33.15. The stock has a fifty day simple moving average of $6.86 and a 200 day simple moving average of $6.89. The company has a quick ratio of 3.31, a current ratio of 3.98 and a debt-to-equity ratio of 0.34.

Insiders Place Their Bets

In other Aspen Aerogels news, CAO Santhosh P. Daniel sold 4,410 shares of the stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $7.31, for a total transaction of $32,237.10. Following the completion of the sale, the chief accounting officer directly owned 19,879 shares in the company, valued at approximately $145,315.49. This trade represents a 18.16% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 3.40% of the company’s stock.

Institutional Trading of Aspen Aerogels

A number of large investors have recently bought and sold shares of the business. FORA Capital LLC grew its holdings in Aspen Aerogels by 138.2% during the 2nd quarter. FORA Capital LLC now owns 29,452 shares of the construction company’s stock worth $174,000 after acquiring an additional 17,090 shares during the period. Tower Research Capital LLC TRC grew its holdings in Aspen Aerogels by 184.6% during the 2nd quarter. Tower Research Capital LLC TRC now owns 7,235 shares of the construction company’s stock worth $43,000 after acquiring an additional 4,693 shares during the period. Voleon Capital Management LP grew its holdings in Aspen Aerogels by 464.8% during the 2nd quarter. Voleon Capital Management LP now owns 248,839 shares of the construction company’s stock worth $1,473,000 after acquiring an additional 204,779 shares during the period. HRT Financial LP grew its stake in shares of Aspen Aerogels by 668.7% in the 2nd quarter. HRT Financial LP now owns 595,742 shares of the construction company’s stock valued at $3,526,000 after buying an additional 518,243 shares during the period. Finally, BNP Paribas Financial Markets grew its stake in shares of Aspen Aerogels by 5.7% in the 2nd quarter. BNP Paribas Financial Markets now owns 411,066 shares of the construction company’s stock valued at $2,434,000 after buying an additional 22,110 shares during the period. 97.64% of the stock is currently owned by institutional investors and hedge funds.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.